Novel combination regimens: Biologics and acitretin for the treatment of psoriasis - A case series

Journal of Dermatological Treatment

Volumn 17, Issue 2, 2006, Pages 86-89

  Conley, Jared ^a   Nanton, Jaleema ^a   Dhawan, Sunil ^b,c   Pearce, Daniel J ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Center for Dermatology Cosmetic and Laser Surgery   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acitretin; Biologics; Combination therapy; Psoriasis; Systemic; Treatment

Indexed keywords

ADALIMUMAB; ALEFACEPT; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; METHOTREXATE; TAZAROTENE; TRIAMCINOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE EXACERBATION; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA;

ACITRETIN; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; BIOLOGICAL RESPONSE MODIFIERS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 33646564044     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630500482928     Document Type: Article

References (3)

1. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-30.
2. Iyer S, Yamauchi P, Lowe NJ. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol. 2002;146:118-21.
3. Stebbins WG, Lebwohl MG. Biologics in combination with nonbiologics: efficacy and safety. Dermatol Ther. 2004;17:432-40.